Akgün, K., Blankenburg, J., Marggraf, M., Haase, R., & Ziemssen, T. (2020). Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis. Front Immunol.
Styl ChicagoAkgün, Katja, Judith Blankenburg, Michaela Marggraf, Rocco Haase, a Tjalf Ziemssen. "Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis." Front Immunol 2020.
Citace podle MLAAkgün, Katja, et al. "Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis." Front Immunol 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..